American Health Packaging recalls Lamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual Dose NDC: 6068…

Recall date

August 27, 2019

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-1847-2019

FDA classification

Class III

Brand / firm

American Health Packaging

Sold / distributed

Nationwide

Why it was recalled

Labeling: Incorrect or Missing Package Insert; an error in the Dosage Forms and Strengths section of the insert that incorrectly lists the tablet description coding for the tablets.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Lamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual Dose NDC: 60687-362-11), Distributed by American Health Packaging, Columbus, OH